FDA NDC Directory · JSON-LD · Markdown

Palonosetron Hydrochloride

NDC 0703-4094 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerTeva Parenteral Medicines, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA090713
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsPALONOSETRON HYDROCHLORIDE (.25 mg/5mL)
Marketing started20180323
Marketing ended20261231
Package count1

External sources

Source: openFDA. Public-domain (CC0).